In a commendable effort, Merck & Co has managed to get a green signal from the US health regulators for a joint pill for all those who are suffering with health concerns of diabetes and high cholesterol.

The Food and Drugs Administration was reported to have given their approval for the hepatitis C drug produced by Merck & Co., which is going to be the first new treatment for the disease in 20-years.

Reports claimed that Merck & Co. and Intercell AG have suspended a vaccination trial. This vaccination was meant for staph infection and this would cause further research and development and to assess the risk and development of this vaccination on a commercial level.

In a recent verdict, the federal drug regulators have rejected the Merck’s plea to approve the prescription of Gardasil to women between the ages of 27 and 45.

The medical giants Sanofi- Aventis and Merck have withdrawn their support from the animal health powerhouse scheme. This is due to the powers of regulation. This move has come as a major setback to the plans made by the companies for the animal care industry. This decision has come after a long delay in the incorporation of the scheme since six months.

German Merck is most likely to lose the battle against the Switzerland’s Novartis AG. As per the reports, the Food and Drug Administration (FDA) has asked Merck to produce concrete evidence to study the potential effects of the multiple sclerosis (MS) pill cladribine on the health of patients.

Fuji film Holdings Corp. will buy two units of Merck & Co. that manufacture biopharmaceuticals as it wants to see growth in the health-care industry to compensate for down going sales in cameras and film.

US Pharmaceutical giant Merck, in collaboration with Wellcome Trust Charity of Britain, has unveiled its plans to start working on rotavirus vaccine, which would be taken orally.

Drugmaker Merck & Co. claimed that on Saturday that a recent study showed that its cholesterol drug Vytorin offered to lower the risk of heart attack, stroke and at the same time need for heart surgeries in some chronic kidney patients by 16 percent.

Merck, Eli Lilly and Pfizer announced a plan to create a not-for-profit company in Asia to speed up Cancer research and treatments.

The Asian Cancer Research Group has set an example of collaboration among major drug companies to combine resources and expertise to rapidly increase the knowledge of a disease and the disease process.